• Profile
Close

Preventive tuberculosis treatment effect on QuantiFERON TB-Gold In-tube testing in a high tuberculosis-endemic Country: A clinical trial

International Journal of Infectious Diseases Dec 05, 2019

Yanga Q, Ruana Q, Liu X, et al. - In this prospective, open-label, controlled study, 513 people with silicosis were randomly chosen for TB preventive treatment with rifapentine and isoniazid or for observation in order to ascertain whether T-cell interferon-γ responses to Mycobacterium tuberculosis-specific antigens could be affected by tuberculosis preventive treatment in a high-endemic country. A total of 220 people were involved in the final analysis, ie, 105 in the prevention and 115 in observation arms. It was discovered that in a high tuberculosis-endemic country, preventive tuberculosis treatment had no influence on interferon-γ responses measuring through serial QuantiFERON-TB Gold In-Tube assays.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay